TD Asset Management »

Monopar Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $201k 3.1k 65.30

More positions owned by TD Asset Management

Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Cibc Cad (CM)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Enbridge (ENB)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Saturn V Capital Management
Vanguard Group
BlackRock
ADAR1 Capital Management
Wellington Management Company
Siren
Deerfield Management Company
TCG Crossover Management
Polar Capital Holdings
Geode Capital Management
Deep Track Capital
Vivo Capital

View all funds holding Monopar Therapeutics